Page 7 - Diabetes

Diabetes a pandemic, needs vaccines, efficacious medication for control

It is estimated that 101 million people in India - around 10 per cent of the country's population - are suffering from diabetes

Want immediate insurance coverage for diabetes? Apply for a customised plan

Though costlier, they offer coverage for both type I and II diabetes, and to those with high levels of HbA1C

Race to develop weight-loss pills has some drugmakers falling behind

Novo and Lilly's experimental obesity pills helped people lose about 15% of body weight, similar to weight-loss shots on the market already, according to findings presented

Pfizer to discontinue development of obesity drug due to side effects

Pfizer has been developing treatments to target weight loss in diabetes and obesity patients, as it races to target a market estimated to reach $100 billion by the end the of decade

Eli Lilly's Mounjaro gives positive results in obese diabetic people

Diabetes occurs when the body loses the ability to control blood sugar, and it's one of the world's most common serious diseases

Diabetic Term Plan for HbA1c < 8 by Bajaj Allianz Life

Bajaj Allianz Life Insurance has launched a term insurance product specifically designed for individuals with type II diabetes and pre-diabetes, says Chief Distribution Officer Dheeraj Sehgal.

Top headlines: Adani draws scrutiny in US, 1.3 bn to have diabetes globally

Business Standard brings you the top headlines at this hour

Over 1.3 billion people globally to have diabetes by 2050, finds study

A loss of the body's ability to control blood sugar levels, diabetes affects one in 10 adults globally and caused 6.7 million deaths in 2021, the International Diabetes Federation estimates

Diabetes cases on a rise in India: Understanding Type 1 and Type 2 diabete

Type 1 diabetes is seen most often in children and young adults, although the disease can occur at any age, but it is less common than type 2 diabetes

Cheap diabetes drug could cut risk of developing long coronavirus: Study

The study involved 1,126 overweight and obese people who were randomly assigned to receive either metformin or a placebo within three days of testing positive for Covid-19

Over 11.4% Indians diabetic, 35.5% suffer from hypertension: Lancet journal

The prevalence of diabetes in India is 11.4 per cent, while 35.5 per cent of people suffer from hypertension, according to the findings of a nationwide survey published in The Lancet Diabetes & Endocrinology journal. The study, conducted by the Madras Diabetes Research Foundation in collaboration with the Indian Council of Medical Research (ICMR) and other institutes, also found that the prevalence of generalised obesity and abdominal obesity in India stood at 28.6 and 39.5 per cent, respectively. The results, assessing the burden of non-communicable diseases (NCD) across the states, are based on a survey of 1,13,043 (over 1.1akh) people (33,537 urban and 79,506 rural residents), in 31 states and Union Territories in the country, between 2008 and 2020. The survey also showed that 35.5 per cent of Indians suffer from hypertension, 15.3 per cent of people have pre-diabetes, while an alarming 81.2 per cent have dyslipidaemia -- the imbalance of lipids such as cholesterol, low-density

India ready to lead technology-driven diabetes care, says Jitendra Singh

Union minister Jitendra Singh on Sunday said India is fast becoming a huge medical tourism hub and it is ready to lead technology-driven diabetes care. Addressing the three-day World Congress of 'Diabetes Technology and Therapeutics 2023' (DTechCon 2023) here, he said the country is being looked up to by the rest of the world in the field of healthcare after the successful handling of the COVID-19 pandemic. "Technologically and in human resources, we are much ahead of most other countries," said Singh, the Minister of State for Personnel. He said India is not only becoming a technology leader, but also a huge medical tourism hub. "India is ready to lead technology-driven diabetes care," said Singh, who is also a renowned diabetologist. He said India is in the frontline of diabetes research in the world and the prevention of diabetes is not only "our duty towards healthcare, but also our duty towards nation building because this is a country with 70 per cent population below the ag

Study claims childhood trauma can lead to develop type 2 diabetes later

The study aimed to determine whether there was a link between childhood adversity and the development of T2D in early adulthood (16-38 years) among men and women

Approx 1 person in 20 is diabetic, 3-5% of new cases linked to Covid: Study

The findings, published in JAMA Network Open, showed that men were more likely to develop diabetes than women

Poor diet linked to 14 million cases of type 2 diabetes globally: Study

Poor diet contributed to over 14.1 million cases of type 2 2 diabetes in 2018, representing over 70 per cent of new diagnoses globally, according to a study. Of the 30 most populated countries studied, India, Nigeria, and Ethiopia had the fewest case of type 2 diabetes related to unhealthy eating, the researchers said. The analysis, published in the journal Nature Medicine, looked at data from 1990 and 2018, providing valuable insight into which dietary factors are driving type 2 diabetes burden by world region. The researchers found that Of the 11 dietary factors considered, three had an outsized contribution to the rising global incidence of type 2 diabetes: Insufficient intake of whole grains, excesses of refined rice and wheat, and the overconsumption of processed meat. Factors such as drinking too much fruit juice and not eating enough non-starchy vegetables, nuts, or seeds, had less of an impact on new cases of the disease, they said. "Our study suggests poor carbohydrate ..

Union Minister Jitendra Singh bats for prevention of diabetes in pregnancy

Union Minister Jitendra Singh Friday made a strong pitch for the prevention of diabetes in pregnancy to prevent the passing of the health condition to future generations. Addressing the annual conference of Diabetes in Pregnancy Study Group of India (DIPSI), Singh said type-2 diabetes has already assumed epidemic proportions in the country which has achieved the dubious distinction of being the 'diabetes capital' of the world. "In an alarming situation like this, unless we can effectively prevent the occurrence of diabetes in pregnant women, it may not be possible to break the chain of Type-2 Diabetes Mellitus getting passed from generation to generation and thus affecting the future generations," he said. Singh, a diabetologist, said a woman affected by gestational diabetes mellitus (GDM) is likely to pass on to her progeny a higher preponderance to develop type-2 diabetes and that too at a relatively younger age. Singh, a founder member of DIPSI, had a special word of appreciatio

Apple Watch blood glucose monitor could revolutionise diabetes care

If perfected, such a breakthrough would be a boon to diabetics and help cement Apple as a powerhouse in health care

Researchers reveal Covid-19 infection increases diabetes, disease risk

This research, Kwan says, is one piece of the puzzle that will help researchers understand how to prevent metabolic as well as cardiovascular disease risk in the future

Drug firm Glenmark gets USFDA nod for generic diabetes drug to market in US

Drug firm Glenmark said it has received approval from the US health regulator to market a generic medication to treat diabetes in the American market. Glenmark Pharmaceuticals Inc, USA, a unit of the company, has received tentative approval from the US Food & Drug Administration (US FDA) for Saxagliptin Tablets in strengths of 2.5 mg and 5 mg, the Mumbai-based drug maker said in a statement. The company's product is the generic version of AstraZeneca AB's Onglyza tablets (2.5 mg and 5 mg), it added. According to IQVIA sales data for the 12-month period ending December 2022, the Onglyza tablets (2.5 mg and 5 mg) achieved annual sales of around USD 122.3 million. Glenmark said its current portfolio consists of 179 products authorised for distribution in the US marketplace. The drug firm has 46 abbreviated new drug applications (ANDAs) pending approval with the USFDA, it added. In addition to these internal filings, Glenmark continues to identify and explore external development ...

Covid's omicron variant, thought to be milder, can increase diabetes risk

Omicron has been seen as a milder version of Covid compared with earlier strains, leading to lower rates of hospitalization and death than delta and the strain that first emerged from China